Search Results 1371-1380 of 17035 for First%2Baid

  1. Cardiovascular Medicine - Clinical trials

    The patient comes first. So the mission and research here is to advance how we can best help the patient, how to make sure the patient comes first in care.

  2. Clinical Trials - INcrease Of VAgal TonE in CHF

    There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent ...

  3. Lisaftoclax (APG-2575) Combined With Azacytidine (AZA) In The Treatment Of Patients With Higher-risk Myelodysplastic Syndrome (GLORA-4). - Mayo Clinic

    Use of moderately potent inducers and moderately potent inhibitors of CYP3A4 within 7 days prior to the first dose of study drug. 5. MDS or other conditions ...

  4. Breast cancer - Doctors and departments - Mayo Clinic

    Joseph Sirven, M.D., Professor of Neurology, Mayo Clinic: Mayo's mission is about the patient. The patient comes first. So the mission and research here is to ...

  5. A Study to Evaluate Events and Benefits of Lipid-lowering in Older Adults - Mayo Clinic

    There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent ...

  6. Atrial fibrillation - Doctors and departments - Mayo Clinic

    The patient comes first. So the mission and research here is to advance how we can best help the patient, how to make sure the patient comes first in care.

  7. Neurology - Clinical trials

    This purpose of this pilot study is to determine if there are changes in mild TBI detectible with MRE. This is the first time this novel technology has been ...

  8. HLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation With Post-Transplantation Cyclophosphamide - Mayo Clinic

    There are also less common very early (phase 0) and later (phase 4) phases. ... first second (FEV1) predicted > 50% based on most recent pulmonary function ...

  9. A Study to Evaluate the Safety and Immunological Effect of Pembrolizumab in Resectable or Borderline Resectable Pancreatic Cancer - Mayo Clinic

    Female subject of childbearing potential should have a negative urine or serum pregnancy within 72 hours prior to receiving the first dose of study medication.

  10. Medical Research & Education - Mayo Clinic News Network

    Mayo scientists explore swabs for early endometrial, ovarian cancer detection featured image ... First · Previous ... 28 · 29 · 30 · 31 · 32 · 33 · 34 ... Next ...